Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
26,650
-100 (-0.37%)
Sep 11, 2026, 3:30 PM KST
| Market Cap | 156.70B -12.8% |
| Revenue (ttm) | 216.55B +4.3% |
| Net Income | 27.53B -12.1% |
| EPS | n/a |
| Shares Out | 5.88M |
| PE Ratio | 5.69 |
| Forward PE | 4.66 |
| Dividend | 900.00 (3.35%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 2,618 |
| Open | 26,650 |
| Previous Close | 26,750 |
| Day's Range | 26,600 - 26,900 |
| 52-Week Range | 24,000 - 31,700 |
| Beta | 0.14 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |